A national collaboration model is proposed for clinical trials, facilitating patient access to trials and bringing growth to Finland
Finland could accelerate clinical trials through a “one-stop shop” model and shared systems and practices. This is outlined in Sitra’s publication FinTrials – National Framework for Clinical Drug Trials (summary in English).
Finland has long been known for its high-quality healthcare and strong research expertise. However, the number of clinical drug trials conducted in recent years has clearly declined. Reasons for this development include fragmented operating models, insufficient national coordination, and slow and complex processes.
“To strengthen Finland’s position as an attractive country for clinical drug trials, we need more cooperation and national-level coordination. Many other European countries, especially the Nordic countries, have shown that national cooperation is an effective way to increase the number of clinical drug trials,” emphasises Petri Lehto, leader of Sitra’s DigiHealth project.
Read full announcement (external link)
Originally published on 14 Nov
Announcements are published as a service to readers. The sender is responsible for all content. Announcements for publication can be submitted to announcements@thehanseatic.com.
